- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05762991
Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion
April 16, 2024 updated by: National Taiwan University Hospital
Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion: A Multihospital Study
The aim of this diagnostic accuracy study is to evaluate the application of artificial intelligence on the diagnosis of Helicobacter pylori infection and premalignant gastric lesions based on upper endoscopic images.
We use techniques of artificial intelligence to analyze the correlation between endoscopic images and urea breath test results/histopathological results.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This study had invited patients to undergo urea breath test, upper gastrointestinal endoscopy, and histology examination.
The study will collect their tests results, upper gastrointestinal endoscopy images, and histopathological results.
Artificial intelligence techniques will be used to analyze the correlation between endoscopic images and urea breath test results/histopathological results.
We aim to establish a telemedicine system to assist clinicians in diagnosing Helicobacter pylori infection and detecting premalignant gastric lesion using upper endoscopic images.
The system will be implemented as a telemedicine service system in the rural areas, for example Matsu Islands.
The baseline histological predictions will be linked to the newly incident gastric cancer.
Study Type
Observational
Enrollment (Estimated)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Tsung-Hsien Chiang, MD,PhD
- Phone Number: 265427 886-2-23123456
- Email: thchiang@ntu.edu.tw
Study Contact Backup
- Name: Yi-Chia Lee, MD, PhD
- Phone Number: 265689 886-2-23123456
- Email: yichialee@ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 10015
- Recruiting
- Yi-Chia Lee
-
Contact:
- Yi-Chia Lee
- Email: yichialee@ntu.edu.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This study will invite patients who need to undergo urea breath test, upper gastrointestinal endoscopy and histology examination.
Description
Inclusion Criteria:
- Age 20-80
- Scheduled urea breath test and endoscopy
Exclusion Criteria:
1. History of gastric surgery
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Helicobacter pylori infection and premalignant gastric lesion
Application of artificial intelligence to analyze the correlation between endoscopic images and urea breath test results/histopathological results.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sensitivity to detect premalignant gastric lesions
Time Frame: Up to 5 years
|
Outcomes include the atrophic gastritis, intestinal metaplasia, and Helicobacter pylori infection
|
Up to 5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Specificity to exclude premalignant gastric conditions
Time Frame: Up to 5 years
|
Outcomes include the atrophic gastritis, intestinal metaplasia, and Helicobacter pylori infection
|
Up to 5 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Areas under the ROC curves
Time Frame: Up to 5 years
|
Outcomes include the atrophic gastritis, intestinal metaplasia, and Helicobacter pylori infection
|
Up to 5 years
|
Gastric cancer incidence
Time Frame: Up to 10 years
|
New incident gastric cancer
|
Up to 10 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Tsung-Hsien Chiang, MD, PhD, National Taiwan University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 24, 2021
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
February 28, 2023
First Submitted That Met QC Criteria
February 28, 2023
First Posted (Actual)
March 10, 2023
Study Record Updates
Last Update Posted (Actual)
April 18, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202111108RINC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
The study was based on the images and histological data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Helicobacter Pylori Infection
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...RecruitingHelicobacter Pylori Infection | Helicobacter Pylori EradicationBangladesh
-
Shandong UniversityRecruitingHelicobacter Pylori Infection | Patient Education | Helicobacter Pylori EradicationChina
-
Shandong UniversityCompletedHelicobacter Pylori Infection Helicobacter Pylori Eradication Patient EducationChina
-
Shanghai Jiao Tong University School of MedicineCompletedCure Rate of Helicobacter Pylori InfectionChina
-
Seoul National University Bundang HospitalRecruitingHelicobacter Pylori Infection | Helicobacter Pylori 23S rRNA Clarithromycin Resistance Mutation | Helicobacter Pylori Associated Gastrointestinal Disease | Helicobacter Pylori Infection, Susceptibility toKorea, Republic of
-
The First Affiliated Hospital of Nanchang UniversityUnknownBacterial Infection Due to Helicobacter Pylori (H. Pylori) | Eradication Therapy of Helicobacter Pylori | Detection of Helicobacter PyloriChina
-
Tanta UniversityNot yet recruitingPersistent Helicobacter Pylori InfectionEgypt
-
Nanjing First Hospital, Nanjing Medical UniversityCompletedHelicobacter Pylori 23S rRNA/gyrA Gene Mutation Detection Kit (Fluorescence PCR Fusion Curve Method)Helicobacter Pylori Infection | Helicobacter Pylori gyrA Levofloxacin Resistance Mutation | Fecal Drug Resistance Gene Detection | Helicobacter Pylori Infection, Susceptibility toChina
-
Kaohsiung Veterans General Hospital.Kaohsiung Medical University Chung-Ho Memorial HospitalCompletedHelicobacter Pylori InfectionTaiwan
-
National Taiwan University HospitalCompleted